Abstract:Introduction: Kashin-Beck disease (KBD) is an endemic osteoarthropathy with pathological changes occurring in growth plate and articular cartilage in humans. It manifests as cartilage degeneration and necrosis. It is postulated that KBD is due to fungal mycotoxins infiltrating the diet and a regional selenium deficiency in the environment providing food sources in a broad belt across China. Previous work has established an in vitro system in which chondrocytes are cultured and an ex vivo cartilage graft is produced. Subjecting these chondrocytes to either selenium (SEL), Nivalenol (NIV) or in combination during the growth of the graft was found to alter the morphology of the cartilage graft. In addition, the quantity of the large aggregating proteoglycan, was significantly reduced in a dose dependent manner in the presence of Nivalenol. This study aimed to examine the composition of aggrecan from grafts grown in the presence of NIV or SEL alone, or in combination to better understand cellular and molecular mechanisms underlying the pathogenesis of KBD. Methods: Chondrocytes (from 7 day old bovine cartilage) were seeded at high density in MilliCell filter inserts (12mm diameter; Millipore, MA). Cultures were maintained for 4 weeks in DMEM supplemented with 20% heat–inactivated FBS, ascorbate (100μg/ml) and TGFs2 (5ng/ml) or additionally supplemented with either SEL , NIV or both at concentrations of 0.01, 0.05 and 0.1μg/ml. Media was refreshed thrice weekly and later analysed. At 4 weeks the cartilage grafts were harvested, weighed and extracted in 4M guanidium chloride (with an inhibitor cocktail) for biochemical analysis of matrix molecules. Residues were papain digested. Glycosaminoglycan concentration was determined using the DMMB assay in all media samples, guanidine extracts and papain digests. Aggrecan and GAG composition was determined using Western blotting with a panel of antibodies recognising chondroitin sulphate (CS), keratan sulphate (KS) and protein core epitopes present in aggrecan. Results: The total GAG synthesised in a 4week period was substantially reduced in chondrocytes cultured in the presence of NIV at 0.05 and 0.1μg/ml and to a lesser extent in those cultures exposed to the highest dose of SEL. However, the amount of GAG released into the media remained fairly constant within the treatment groups, but a marked reduction was apparent in the guanidine extracts of the cartilage grafts. Western blot analysis with a series of antibodies on guanidine extracted aggrecan showed no substantial changes in the core protein molecular weights however analysis demonstrated that KS was reduced in NIV treated cultures. Results also indicated that NIV treated cultures appeared to contain less CS substitutions on the aggrecan core protein. Discussion: The GAG concentration data indicates that there is an inability of the GAG to remain within the cartilage grafts extracellular matrix. when treated with NIV. Western blot analysis indicates minor changes in the composition of the aggrecan in relation to protein core length and CS/KS side chain substitutions or length. Further work will investigate the proportion of aggrecan able to form high molecular weight aggregates, the metabolism of link protein and hyaluronan.

Effects of nivalenol and selenium on the metabolism of aggrecan in chondrocytes

The effect of Nivalenol on the metabolism of Hyaluronic Acid

Effects of Nivalenol and Selenium on CD44 Metabolism in Chondrocytes

Influence of nivalenol on aggrecan synthesis of cultured chondrocytes

The Effect of Nivalenol on Metabolism of Cultured Chondrocytes and the Protection of Selenium

[Effect of Nivalenol and Selenium on IL-1beta and TNF-alpha Secretion in Cultured Chondrocytes].

Disturbance of nivalenol on expression of adhesion molecule CD44 on surface of cultured chondrocytes

Effects of DON toxin and selenium on sulphate modification of aggrecan

CARTILAGE MATRIX METABOLISM IN AN IN VITRO CULTURE SYSTEM THAT MIMICS CARTILAGE PATHOLOGY IN KASHIN-BECK DISEASE

THE EFFECT ON PROTEOGLYCAN METABOLISM OF DEOXYNIVALENOL AND SELENIUM IN THE CULTURED HUMAN FETAL CHONDROCYTES IN VITRO

Effects of the Mycotoxin Nivalenol on Bovine Articular Chondrocyte Metabolism in Vitro

The Effects of Mycotoxins and Selenium Deficiency on Tissue-Engineered Cartilage

The Effect of Nivalenol and the Protection of Selenium on DNA of Cultured Chondrocytes

The experimental study of effect of mycotoxin DON, T-2 and NIV on the cultural chondrocytes

Effects of T-2 Toxin and Selenium on Expression of Aggrecanase in Human Chondrocyte

Effects of Moniliformin and Selenium on Human Articular Cartilage Metabolism and Their Potential Relationships to the Pathogenesis of Kashin-Beck Disease

Effectiveness of Selenium on Chondrocyte Glycoprotein Glycosylation Which Play Important Roles in the Pathogenesis of an Endemic Osteoarthritis, Kashin–Beck Disease

Effects of Selenium Nanoparticles and Sodium Selenite on Apoptosis and Reactive Oxygen Species in Chondrocytes from Articular Cartilage in Patients with Kashin-Beck Disease

Inhibiting the aberrant activation of Wnt/-catenin signaling by selenium supplementation ameliorates deoxynivalenol-induced toxicity and catabolism in chondrocytes

Effects of Selenium And/or Iodine Deficiency on Chondrocyte Apoptosis in Rats

The effect of aging on aggrecan catabolism in culutured chondrecytes